Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 3

Sponsor Class

OTHER 10INDUSTRY 4NIH 3NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3Other hematologic neoplasm 1

Conditions

Lymphoma, Non-Hodgkin 2HIV Infections 2Acquired Immunodeficiency Syndrome 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia, Biphenotypic, Acute 1

Interventions

Cyclophosphamide 178Radiotherapy 147Paclitaxel 128Carboplatin 124Bevacizumab 123Cisplatin 119Doxorubicin 111Fluorouracil 107Etoposide 102Filgrastim 99Vincristine 88Leucovorin 82Bortezomib 80Gemcitabine 76aldesleukin 74Sorafenib 70Cytarabine 70Taxes 69fludarabine phosphate 67Irinotecan 66Docetaxel 64Oxaliplatin 60sargramostim 58Sirolimus 58temsirolimus 56Erlotinib Hydrochloride 56Methotrexate 55Rituximab 54Vorinostat 52Radiation 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × NIH × Allopurinol × Clear all
NCT00061945 2022-05-03

Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
302 enrolled 11 charts
LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00000658 2021-11-03

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
250 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections

NCT00000703 2021-11-03

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Completed
45 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡